Preview

Cancer Urology

Advanced search

Medical, social, and economic perspectives of health care development. Prostate Cancer Early Diagnosis and Screening Program

https://doi.org/10.17650/1726-9776-2022-18-2-217-225

Abstract

Aim. To improve diagnostics and screening of prostate cancer to ensure early detection of malignant tumors.

Materials and methods. We analyzed the population size and structure in the region in 2005–2010. The primary diagnostics of prostate cancer in regional healthcare institutions allowed the detection of locally advanced tumors and generalized cancer. Such diagnostic approaches can produce only accidental diagnosis since they lack proper systematization, organization, and control.

Results. We have developed and implemented into clinical practice a long-term Program for Prostate Cancer Early Diagnosis and Screening. It includes a diagnostic algorithm for prostate cancer that was modified for clinical use. Screening starts with the PSA blood test performed annually. Patients with PSA level >10 ng/mL should undergo additional diagnostic procedures. The Program implies active use of currently available information technologies to implement a unified routing scheme for cancer patients, execute measures for early cancer diagnosis, and warrant promptness and reliability of the cancer registry.

Conclusion. Implementation of the long-term Program for Prostate Cancer Early Diagnosis and Screening will help to improve prostate cancer diagnosis, and, therefore, treatment outcomes.

About the Authors

A. O. Leonova
Omsk Clinical Oncological Dispensary
Russian Federation

Build. 1, 9 Zavertyaeva St., Omsk 644013


Competing Interests:

The authors declare no conflict of interest



E. I. Kopyltsov
Omsk Clinical Oncological Dispensary; Siberian State University of Physical Education and Sports
Russian Federation

Build. 1, 9 Zavertyaeva St., Omsk 644013; 144 Maslennikova St., Omsk 644009


Competing Interests:

The authors declare no conflict of interest



B. Ya. Alekseev
P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia; Medical Institute of Continuing Education, Moscow State University of Food Production
Russian Federation

3 2nd Botkinskiy Proezd, Moscow 125284; 11 Volokolamskoe Shosse, Moscow 125080


Competing Interests:

The authors declare no conflict of interest



I. A. Sikhvardt
Omsk Clinical Oncological Dispensary; Siberian State University of Physical Education and Sports
Russian Federation

Build. 1, 9 Zavertyaeva St., Omsk 644013; 144 Maslennikova St., Omsk 644009


Competing Interests:

The authors declare no conflict of interest



Yu. N. Yurgel
Omsk Clinical Oncological Dispensary
Russian Federation

Build. 1, 9 Zavertyaeva St., Omsk 644013


Competing Interests:

The authors declare no conflict of interest



O. V. Leonov
Omsk Clinical Oncological Dispensary; Siberian State University of Physical Education and Sports
Russian Federation

Oleg Vladimirovich Leonov

Build. 1, 9 Zavertyaeva St., Omsk 644013; 144 Maslennikova St., Omsk 644009


Competing Interests:

The authors declare no conflict of interest



V. A. Vodolazskiy
Omsk Clinical Oncological Dispensary
Russian Federation

Build. 1, 9 Zavertyaeva St., Omsk 644013


Competing Interests:

The authors declare no conflict of interest



I. A. Durnev
Omsk Clinical Oncological Dispensary
Russian Federation

Build. 1, 9 Zavertyaeva St., Omsk 644013


Competing Interests:

The authors declare no conflict of interest



References

1. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization, 2014. 114 р.

2. Taitt H.E. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health 2018;12(6):1807–23. DOI: 10.1177/1557988318798279

3. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70(1):7–30. DOI: 10.3322 / caac.21590

4. Rawla P. Epidemiology of prostate cancer. World J Oncol 2019;10(2):63–89. DOI: 10.14740/wjon1191

5. State of oncological care in Russia in 2010. Eds.: V.I. Chissov, V.V. Starinskiy, G.V. Petrova. Moscow: FGU “MNIOI im. P.A. Gertsena” Minzdravsotsrazvitiya Rossii, 2011. 188 p. (In Russ.).

6. Vickers A.J. Prediction models in cancer care. CA Cancer J Clin 2011;61(5):315–26. DOI: 10.3322/caac.20118

7. State of oncological care in Russia in 2012. Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: FGBU “MNIOI im. P.A. Gertsena” Minzdrava Rossii, 2013. 231 p. (In Russ.).

8. Guide to cancer early diagnosis. Geneva: World Health Organization, 2018. 38 р. 9. Bray F., Ferley F., Soerjomataram I. et. al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–24. DOI: 10.3322/caac.21492

9. Rundle A., Neckerman K.M., Sheehan D. et al. A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer. Cancer Causes Control 2013;24(2):297–303. DOI: 10.1007/s10552­012­0108­6

10. Axel E.M., Matveev V.B. Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR. Onkourologiya = Cancer Urology 2019;15(2):15–24. (In Russ.). DOI: 10.17650/1726­9776­ 2019­15­2­15­24

11. Patel N.H., Bloom J., Hillelsohn J. et al. Prostate cancer screening trends after United States preventative services task force guidelines in an underserved population. Health Equity 2018;2(1): 55–61. DOI: 10.1089/heq.2018.0004

12. Carter H.B., Albertsen P.C., Barry M.J. et al. Early detection of prostate cancer: AUA Guideline. J Urol 2013;190(2):419–26. DOI: 10.1016/j.juro.2013.04.119

13. Hsing A.W., Chokkalingam A.P. Prostate cancer epidemiology. Front Biosci 2006;11: 1388–413. DOI: 10.2741/1891

14. Postma R., Schröder F.H., van Leenders G.J.L.H. et. al. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) – section Rotterdam. A comparison of two rounds of screening. Eur Urol 2007;52(1):89–97. DOI: 10.1016/j.eururo.2007.01.030

15. Preventive Services Task Force (Moyer Va. U.S.). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157(2):120–34. DOI: 10.7326/0003­4819­157­2201207170­00459

16. Brett A.S., Ablin R.J. Prostate­cancer screening – what the US Preventive Services Task Force left out. N Engl J Med 2011;365(21):1949–51. DOI: 10.1056/NEJMp1112191

17. Fenton J.J., Weyrich M.S., Durbin S. et al. Prostate­specific antigen­based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2018;319(18):1914–31. DOI: 10.1001/jama.2018.3712

18. Zhuravlev V.N., Bazhenov I.V., Zyryanov A.V. et al. Organization of early diagnosis of oncourological diseases in the Sverdlovsk region. Onkourologiya = Cancer Urology 2009;5(1):71–5. (In Russ.).

19. Engalychev F.S., Mironov M.A., Galkina N.G. et al. Results of a goal­oriented prostate cancer screening program in the Penza region. Onkourologiya = Cancer Urology 2012;8(1):62–5. (In Russ.).

20. Krasnyi S.A., Tarend D.T., Semenov S.A. The results of prostate cancer screening and the problem of the hyperdiagnosis of the disease in the Republic of Belarus. Onkourologiya = Cancer Urology 2016; 12(1):58–62. (In Russ.). DOI: 10.17650/1726­9776­2016­12­1­58­62

21. Vazhenin A.V., Karnaukh P.A., Kipriyanov E.A. et al. Early diagnosis of prostate cancer on the example of the contingent of employees of an enterprise in the Russian Federation. Tyumenskiy meditsinskiy zhurnal = Tyumen Medical Journal 2015;17(3): 16–9. (In Russ.)

22. Heidenreich A., Abrahamsson P.A., Artibani W. et al. Early detection of prostate cancer: European Association of Urology Recommendation. Eur Urol 2013;64(3):347–54. DOI: 10.1016/j.eururo.2013.06.051

23. Danilov A.I., Bizenkov A.S. Health care system reforming in modern Russia. Vestnik Smolenskoy gosudarstvennoy meditsinskoy akademii = Bulletin of the Smolensk State Medical Academy 2019;18(1):202–5. (In Russ.).

24. Novikov D.A. The theory of management of organizational systems. 2nd edn. Moscow: Fizmatlit, 2007. 584 р. (In Russ.).

25. Spurgeon P., Mazelan P., Barwell F. A management control approach to monitor large­scale change: an illustration in the context of reconfiguration. Health Serv Manage Res 2011;24(1):19–28. DOI: 10.1258/hsmr.2010.010010

26. Organization personnel management. Ed.: A.Ya. Kibanov. Moscow: Infra­M, 2011. 304 р. (In Russ.).

27. Shapiro S.A., Shataeva O.V. Fundamentals of human resource management in modern organizations. Moscow: GrossMedia, ROSBUKH, 2008. 468 р. (In Russ.).

28. Decree of the Government of the Omsk Region dated July 19, 2010 № 140­п “On the approval of the long­term target program of the Omsk Region “Regional project “Oncology” for 2011–2015”. (In Russ.).


Review

For citations:


Leonova A.O., Kopyltsov E.I., Alekseev B.Ya., Sikhvardt I.A., Yurgel Yu.N., Leonov O.V., Vodolazskiy V.A., Durnev I.A. Medical, social, and economic perspectives of health care development. Prostate Cancer Early Diagnosis and Screening Program. Cancer Urology. 2022;18(2):217-225. (In Russ.) https://doi.org/10.17650/1726-9776-2022-18-2-217-225

Views: 367


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)
X